Akruti Nirman has announced its fourth quarter results. The company has recorded net profit of Rs 57.18 crore for its fourth quarter ended June 30, 2007, as against Rs 571.8 million in the corresponding period of the last year.

The company posted net sales of Rs 92.68 crore as compared to Rs 926.8 million in the same period of the last year..

In afternoon trade, IFB Industries beat the upper route of 20% at Rs 27.65 on reporting a 1,143.27% increase in net profit in Q4 March 2007. The final results were declared during the market hours.
During the day, the scrip touched an intraday high of Rs 27.65 and an intraday low of Rs 26. On 3 November, it touched a 52-week high of Rs 29.95 and a 52-week low of Rs 14.50 on 4 April 2007.
The IFB Industries scrip gained 32.47% over the last one month to 29 June 2007 as compared to the Sensex’s return of 0.73%. Over the last one quarter, the company outperformed the market gaining 34.40% as compared to the Sensex’s admiration of 12.07%.

On reporting a 618.19% increase in net profit in Q2 May 2007, Pfizer lifted 1.18% to Rs 820.10 in a

Colgate Palmolive Co. said, “Second quarter profit jumped more than analysts estimated on increased sales in Europe and Latin America and a weaker U.S. Dollar.”

Africa has been a hushed moneymaker for India’s major drug manufacturing company Ranbaxy making a